Reductions in myeloid-derived suppressor cells and lung metastases using AZD4547 treatment of a metastatic murine breast tumor model
- PMID: 24642893
- DOI: 10.1159/000358640
Reductions in myeloid-derived suppressor cells and lung metastases using AZD4547 treatment of a metastatic murine breast tumor model
Abstract
Background: AZD4547, a small-molecule inhibitor targeting the tyrosine kinase of Fibroblast Growth Factor Receptors (FGFRs), is currently under phase II clinical study for human subjects having breast cancer, while the underlying mechanism remains elusive. The aim of this study is to explore the potential mechanism by which AZD4547 inhibits breast tumor lung metastases at the level of the tumor microenvironment.
Methods: First, through in vitro experiments, we investigated the efficacy of the FGFRs inhibitor AZD4547 on 4T1 tumor cells for their proliferation, apoptosis, migration, and invasion. Second, by in vivo animal experiments, we evaluated the effects of AZD4547 on tumor growth and lung metastases in 4T1 tumor-bearing mice. Finally, we examined the impact of AZD4547 on the infiltration of myeloid-derived suppressor cells (MDSCs) in lung, spleens, peripheral blood and tumor.
Results: Through this study we found that AZD4547 could efficiently suppress tumor 4T1 cells through restraining their proliferation, blocking migration and invasion, and inducing apoptosis in vitro. In animal model we also demonstrated that AZD4547 was able to inhibit tumor growth and lung metastases, consistent with the decreased MDSCs accumulation in the tumor and lung tissues, respectively. Moreover, the reduced number of MDSCs in peripheral blood and spleens were also observed in the AZD4547-treated mice. Importantly, through the AZD4547 treatment, the CD4(+) and CD8(+) T-cells were significantly increased in tumor and spleens.
Conclusion: Our studies showed that AZD4547 can inhibit breast cancer cell proliferation, induce its apoptosis and block migration and invasion in vitro and suppress tumor growth and lung metastases by modulating the tumor immunologic microenvironment in vivo.
© 2014 S. Karger AG, Basel.
Similar articles
-
Translating the therapeutic potential of AZD4547 in FGFR1-amplified non-small cell lung cancer through the use of patient-derived tumor xenograft models.Clin Cancer Res. 2012 Dec 15;18(24):6658-67. doi: 10.1158/1078-0432.CCR-12-2694. Epub 2012 Oct 18. Clin Cancer Res. 2012. PMID: 23082000
-
FGFR inhibitor, AZD4547, impedes the stemness of mammary epithelial cells in the premalignant tissues of MMTV-ErbB2 transgenic mice.Sci Rep. 2017 Sep 12;7(1):11306. doi: 10.1038/s41598-017-11751-7. Sci Rep. 2017. PMID: 28900173 Free PMC article.
-
Inhibition of FGFR signaling by PD173074 improves antitumor immunity and impairs breast cancer metastasis.Breast Cancer Res Treat. 2014 Feb;143(3):435-46. doi: 10.1007/s10549-013-2829-y. Epub 2014 Jan 8. Breast Cancer Res Treat. 2014. PMID: 24398778
-
Myeloid suppressor cells and immune modulation in lung cancer.Immunotherapy. 2012 Mar;4(3):291-304. doi: 10.2217/imt.11.178. Immunotherapy. 2012. PMID: 22401635 Free PMC article. Review.
-
Reciprocal relationship between myeloid-derived suppressor cells and T cells.J Immunol. 2013 Jul 1;191(1):17-23. doi: 10.4049/jimmunol.1300654. J Immunol. 2013. PMID: 23794702 Free PMC article. Review.
Cited by
-
Therapeutically Targeting Cancers That Overexpress FOXC1: A Transcriptional Driver of Cell Plasticity, Partial EMT, and Cancer Metastasis.Front Oncol. 2021 Sep 3;11:721959. doi: 10.3389/fonc.2021.721959. eCollection 2021. Front Oncol. 2021. PMID: 34540690 Free PMC article. Review.
-
Comprehensive analysis of the prognostic value and immune infiltration of FGFR family members in gastric cancer.Front Oncol. 2022 Sep 6;12:936952. doi: 10.3389/fonc.2022.936952. eCollection 2022. Front Oncol. 2022. PMID: 36147913 Free PMC article.
-
Age and Mutations as Predictors of the Response to Immunotherapy in Head and Neck Squamous Cell Cancer.Front Cell Dev Biol. 2020 Dec 9;8:608969. doi: 10.3389/fcell.2020.608969. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 33363171 Free PMC article.
-
Small Molecule Targeting Immune Cells: A Novel Approach for Cancer Treatment.Biomedicines. 2023 Sep 24;11(10):2621. doi: 10.3390/biomedicines11102621. Biomedicines. 2023. PMID: 37892995 Free PMC article. Review.
-
Fibrocytes: A Novel Stromal Cells to Regulate Resistance to Anti-Angiogenic Therapy and Cancer Progression.Int J Mol Sci. 2017 Dec 29;19(1):98. doi: 10.3390/ijms19010098. Int J Mol Sci. 2017. PMID: 29286323 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials